PMV Pharmaceuticals (PMVP) Tax Provisions (2019 - 2025)

PMV Pharmaceuticals' (PMVP) quarterly Tax Provisions came in at $26000.0 in Q4 2025, up 533.33% on a QoQ basis from -$6000.0 in Q3 2025.

PMV Pharmaceuticals (PMVP) Tax Provisions (2019 - 2025) Analysis & Trends

PMV Pharmaceuticals (PMVP) has 7 years of Tax Provisions data on file, last reported at $26000.0 in Q4 2025.

Quarterly Tax Provisions changed N/A year-over-year to $26000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $25000.0 (up 100.14% YoY) and the FY2025 annual result came in at -$2.2 million, up 86.51% from the prior year.
Tax Provisions advanced to $26000.0 in Q4 2025, from -$6000.0 in the prior quarter.
In the past five years, Tax Provisions ranged from a high of $74000.0 in Q3 2024 to a low of -$16.2 million in Q2 2024.
A 5-year average of -$1.3 million and a median of $500.0 in 2022 frame the typical range for Tax Provisions.
The widest YoY moves for Tax Provisions: up 7500.0% in 2024, down 404425.0% in 2024.
Tracing PMVP's Tax Provisions over 5 years: stood at $19000.0 in 2021, then sank by 147.37% to -$9000.0 in 2022, then soared by 88.89% to -$1000.0 in 2023, then soared by 7500.0% to $74000.0 in 2024, then plunged by 64.86% to $26000.0 in 2025.
The last three Tax Provisions figures came in at $26000.0 (Q4 2025), -$6000.0 (Q3 2025), and $5000.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	PMV Pharmaceuticals	69.94 Mn	-9.49 Mn	-	3,000.00

Download Data